Biobeat Raises $45M in Series B
Biobeat has successfully raised $45M in a Series B at a $200M valuation led by Awz Ventures, iAngels.
Company Overview
Biobeat is a HealthTech company headquartered in Petah Tikva, Israel, founded in 2016 with 100+ employees.
Non-invasive continuous monitoring wearables
Fundraising Details
- Amount Raised: $45M
- Round Type: Series B
- Valuation: $200M
- Date: 2021-07-13
- Investors: Awz Ventures, iAngels
About Biobeat
Non-invasive continuous monitoring wearables The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Petah Tikva, Israel
- Founded: 2016
- Team Size: 100+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Biobeat's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Biobeat's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $200M valuation marks an important milestone for Biobeat, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Biobeat is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2021-07-13. For more information about Biobeat, visit their headquarters at Petah Tikva, Israel.
